Benzinga's Top #PreMarket Gainers

By: via Benzinga
SAGE Therapeutics Inc (NASDAQ: SAGE) shares rose 19.76 percent to $90 in pre-market trading after the company reported positive ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.